Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Haematologica|March 5, 2026
Prognosis in marginal zone lymphoma: a comprehensive reviewAnnalisa Talami, Maria Elena Nizzoli, Emilia Cappello, et al.
European Journal of Haematology|October 27, 2024
Comparative Analysis of Bispecific Antibodies and CAR T-Cell Therapy in Follicular LymphomaFortunato Morabito, Enrica Antonia Martino, Maria Elena Nizzoli, et al.
Blood Advances|September 17, 2021
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemiaSimone Ragaini, Sarah Wagner, Giovanni Marconi, et al.
Biomedicines|August 27, 2021
How to Improve Prognostication in Acute Myeloid Leukemia with CBFB-MYH11 Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) MonitoringAnnalisa Talami, Francesca Bettelli, Valeria Pioli, et al.
Leukemia Research|January 1, 2021
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patientsGiovanni Marconi, Stefano De Polo, Giovanni Martinelli, et al.
International Journal of Molecular Sciences|September 10, 2021
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid LeukemiaFabio Forghieri, Giovanni Riva, Ivana Lagreca, et al.
European Journal of Haematology|March 8, 2020
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemiaGiovanni Marconi, Annalisa Talami, Maria Chiara Abbenante, et al.
Eclinicalmedicine|April 18, 2024
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatmentLuca Arcaini, Côme Bommier, Juan Pablo Alderuccio, et al.
Pageof 1